Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC MutagenesisMia Petljak, Michael R. Stratton, Ludmil B. Alexandrov et al.|Cell|2019Cited by 446
A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non–Small Cell Lung CancerDaniel A. Goldstein, Alona Zer, Conor Steuer et al.|JNCI Journal of the National Cancer Institute|2017Cited by 102